Steroidogenic control of liver metabolism through a nuclear receptor-network
Objective: Coupling metabolic and reproductive pathways is essential for the survival of species. However, the functions of steroidogenic enzymes expressed in metabolic tissues are largely unknown. Methods and results: Here, we show that in the liver, the classical steroidogenic enzyme Cyp17a1 forms...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Molecular Metabolism |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221287781930910X |
id |
doaj-f03fe7de90804886b4db2443d1f7e1c8 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alexandra Milona Vittoria Massafra Harmjan Vos Jyoti Naik Natalia Artigas Helen A.B. Paterson Ingrid T.G.W. Bijsmans Ellen C.L. Willemsen Jose M. Ramos Pittol Irene Miguel-Aliaga Piter Bosma Boudewijn M.T. Burgering Catherine Williamson Santiago Vernia Waljit S. Dhillo Saskia W.C. van Mil Bryn M. Owen |
spellingShingle |
Alexandra Milona Vittoria Massafra Harmjan Vos Jyoti Naik Natalia Artigas Helen A.B. Paterson Ingrid T.G.W. Bijsmans Ellen C.L. Willemsen Jose M. Ramos Pittol Irene Miguel-Aliaga Piter Bosma Boudewijn M.T. Burgering Catherine Williamson Santiago Vernia Waljit S. Dhillo Saskia W.C. van Mil Bryn M. Owen Steroidogenic control of liver metabolism through a nuclear receptor-network Molecular Metabolism |
author_facet |
Alexandra Milona Vittoria Massafra Harmjan Vos Jyoti Naik Natalia Artigas Helen A.B. Paterson Ingrid T.G.W. Bijsmans Ellen C.L. Willemsen Jose M. Ramos Pittol Irene Miguel-Aliaga Piter Bosma Boudewijn M.T. Burgering Catherine Williamson Santiago Vernia Waljit S. Dhillo Saskia W.C. van Mil Bryn M. Owen |
author_sort |
Alexandra Milona |
title |
Steroidogenic control of liver metabolism through a nuclear receptor-network |
title_short |
Steroidogenic control of liver metabolism through a nuclear receptor-network |
title_full |
Steroidogenic control of liver metabolism through a nuclear receptor-network |
title_fullStr |
Steroidogenic control of liver metabolism through a nuclear receptor-network |
title_full_unstemmed |
Steroidogenic control of liver metabolism through a nuclear receptor-network |
title_sort |
steroidogenic control of liver metabolism through a nuclear receptor-network |
publisher |
Elsevier |
series |
Molecular Metabolism |
issn |
2212-8778 |
publishDate |
2019-12-01 |
description |
Objective: Coupling metabolic and reproductive pathways is essential for the survival of species. However, the functions of steroidogenic enzymes expressed in metabolic tissues are largely unknown. Methods and results: Here, we show that in the liver, the classical steroidogenic enzyme Cyp17a1 forms an essential nexus for glucose and ketone metabolism during feed-fast cycles. Both gain- and loss-of-function approaches are used to show that hepatic Cyp17a1 is induced by fasting, catalyzes the production of at least one hormone-ligand (DHEA) for the nuclear receptor PPARα, and is ultimately required for maintaining euglycemia and ketogenesis during nutrient deprivation. The feedback-loop that terminates Cyp17a1-PPARα activity, and re-establishes anabolic liver metabolism during re-feeding is mapped to postprandial bile acid-signaling, involving the receptors FXR, SHP and LRH-1. Conclusions: Together, these findings represent a novel paradigm of homeostatic control in which nutritional cues feed-forward on to metabolic pathways by influencing extragonadal steroidogenesis. Keywords: FXR, FGF21, Bile acids, Liver, Metabolism, Fasting, Gluconeogenesis, Diabetes, Steroidogenesis, Cyp17a1 |
url |
http://www.sciencedirect.com/science/article/pii/S221287781930910X |
work_keys_str_mv |
AT alexandramilona steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT vittoriamassafra steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT harmjanvos steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT jyotinaik steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT nataliaartigas steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT helenabpaterson steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT ingridtgwbijsmans steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT ellenclwillemsen steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT josemramospittol steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT irenemiguelaliaga steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT piterbosma steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT boudewijnmtburgering steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT catherinewilliamson steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT santiagovernia steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT waljitsdhillo steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT saskiawcvanmil steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork AT brynmowen steroidogeniccontroloflivermetabolismthroughanuclearreceptornetwork |
_version_ |
1724722318880538624 |
spelling |
doaj-f03fe7de90804886b4db2443d1f7e1c82020-11-25T02:54:17ZengElsevierMolecular Metabolism2212-87782019-12-0130221229Steroidogenic control of liver metabolism through a nuclear receptor-networkAlexandra Milona0Vittoria Massafra1Harmjan Vos2Jyoti Naik3Natalia Artigas4Helen A.B. Paterson5Ingrid T.G.W. Bijsmans6Ellen C.L. Willemsen7Jose M. Ramos Pittol8Irene Miguel-Aliaga9Piter Bosma10Boudewijn M.T. Burgering11Catherine Williamson12Santiago Vernia13Waljit S. Dhillo14Saskia W.C. van Mil15Bryn M. Owen16MRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsAmsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&M, Meibergdreef 69-71, 1105 BK, Amsterdam, the NetherlandsMRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomMRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsMRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomAmsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&M, Meibergdreef 69-71, 1105 BK, Amsterdam, the NetherlandsCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the NetherlandsSchool of Life Course Science, Kings College London, London, United KingdomMRC London Institute of Medical Sciences (LMS), London, United Kingdom; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, United KingdomSection of Endocrinology & Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United KingdomCenter for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands; Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&M, Meibergdreef 69-71, 1105 BK, Amsterdam, the Netherlands; Corresponding author. UMC Utrecht Center for Molecular Medicine, PO Box 85060, 3508 AB, Utrecht, the Netherlands.Section of Endocrinology & Investigative Medicine, Division of Diabetes, Endocrinology, and Metabolism, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London, United Kingdom; Corresponding author. Section of Investigative Medicine, Imperial College London, Du Cane Road, London, W12 0NN, United Kingdom.Objective: Coupling metabolic and reproductive pathways is essential for the survival of species. However, the functions of steroidogenic enzymes expressed in metabolic tissues are largely unknown. Methods and results: Here, we show that in the liver, the classical steroidogenic enzyme Cyp17a1 forms an essential nexus for glucose and ketone metabolism during feed-fast cycles. Both gain- and loss-of-function approaches are used to show that hepatic Cyp17a1 is induced by fasting, catalyzes the production of at least one hormone-ligand (DHEA) for the nuclear receptor PPARα, and is ultimately required for maintaining euglycemia and ketogenesis during nutrient deprivation. The feedback-loop that terminates Cyp17a1-PPARα activity, and re-establishes anabolic liver metabolism during re-feeding is mapped to postprandial bile acid-signaling, involving the receptors FXR, SHP and LRH-1. Conclusions: Together, these findings represent a novel paradigm of homeostatic control in which nutritional cues feed-forward on to metabolic pathways by influencing extragonadal steroidogenesis. Keywords: FXR, FGF21, Bile acids, Liver, Metabolism, Fasting, Gluconeogenesis, Diabetes, Steroidogenesis, Cyp17a1http://www.sciencedirect.com/science/article/pii/S221287781930910X |